Entity

Time filter

Source Type

Asseco Poland SA is the largest corporation in the technology sector quoted on the Warsaw Stock Exchange. It was established in 1991 and provided computer software to the banking industry. The current corporation is the result of a merger between ASSET Soft AS and COMP Rzeszów SA. It currently provides a variety of services to the banking and finance industries. Its headquarters are in Rzeszów, Poland. Wikipedia.


Parol M.,Warsaw University of Technology | Romanik T.,P.P.H. WR Sp. Z O. O. | Wojcik L.,Asseco Poland
Przeglad Elektrotechniczny | Year: 2010

The article concerns monitoring and remote control of intelligent installation KNX TP via mobile phone. Issues connected with generic and logical structure of the control system and with creation of a software application, which enables realisation of the mentioned tasks by means of mobile phone have been discussed. Practical aspects concerning creation of the software application and example of its implementation in laboratory conditions have been presented. Needed devices and software components have been characterised. Source


Nowakowski A.,Military Institute of Medicine | Cybulski M.,Medical University of Lublin | Sliwczynski A.,National Health Fund | Chil A.,Swietokrzyskie Cancer Center | And 4 more authors.
BMC Cancer | Year: 2015

Background: Well-organised quality-controlled screening can substantially reduce the burden of cervical cancer (CC). European guidelines (EuG) for quality assurance in CC screening provide guidance on all aspects of an organised screening programme. Organised CC screening in Poland was introduced in 2007. The purpose of our study was to analyse: (i) adherence of the programme to EuG; (ii) programme process and performance indicators; (iii) impact of the programme on the incidence of and mortality from CC. Methods: Available data on the policy, structure and functioning of the Polish programme were compared with the major points of the EuG. Data on the process, and available performance indicators were drawn from the screening database and other National Health Fund (NHF) systems. Joinpoint regression was used to assess changes in CC incidence and mortality trends. Results: The Polish programme adheres partially to EuG in terms of policy and organisation. Only a limited set of performance indicators can be calculated due to screening database incompleteness or lack of linkage between existing databases. The screening database does not include opportunistic smears collected within NHF-reimbursed or private care. The organised programme coverage rate fluctuated from 21% to 27% between 2007-2013. In 2012 the coverage reached 35% after combining both organised and opportunistic smears reimbursed by the NHF. In 2012 the number of smears reimbursed by NHF was 60% higher in opportunistic than in organised screening with significant overlap. Data from the private sector are not recorded. Depending on years, 30-50% of women referred for colposcopy/biopsy because of abnormal Pap smears were managed within the programme. The age-standardised CC incidence and mortality dropped linearly between 1999 and 2011 without evidence of a period effect. Conclusions: The Polish organised cervical screening programme is only partially adherent to evidence-based EuG. Its implementation has not influenced the burden of CC in the country so far. Changes with special focus on increasing coverage, development of information systems and assessment of quality are required to increase programme adherence to EuG and to measure its effectiveness. Our findings may be useful to improve the Polish programme and those implemented or planned in other countries. © Nowakowski et al.; licensee BioMed Central. Source


Bielecki A.,Jagiellonian University | Buratowski T.,AGH University of Science and Technology | Smigielski P.,Asseco Poland
Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics) | Year: 2012

In this paper the approach to on-line object recognition for autonomous flying agent is considered. The method is divided into two parts. First the algorithm for scene objects vectorization is introduced. As the second step of the overall method we present the rotation and scale invariant algorithm for vectorized object identification based on syntactic language. © 2012 Springer-Verlag Berlin Heidelberg. Source


Bielecki A.,AGH University of Science and Technology | Buratowski T.,AGH University of Science and Technology | Smigielski P.,Asseco Poland
Expert Systems with Applications | Year: 2013

In this paper the problem of a vision system implementation for autonomous flying agents is considered in the context of industrial inspection tasks performed by unmanned aerial vehicles. A syntactic algorithm of a two-dimensional object vectorization and recognition is proposed. An algorithm of two-dimensional map recognition has been introduced as well. The algorithms have been tested by using both artificial data and real data-The satellite image. They have turned out to be effective. © 2012 Elsevier Ltd. All rights reserved. Source


Cybulski M.,Medical University of Lublin | Jarosz B.,Medical University of Lublin | Nowakowski A.,Medical University of Lublin | Nowakowski A.,Military Medical Institute | And 3 more authors.
Gynecologic Oncology | Year: 2012

Objective: Ovarian cancer is the most lethal of all gynecologic malignancies. It is characterized by the spread of intraperitoneal tumors, accumulation of ascites, and formation of tumor blood vessels. Cyclin I has been linked with angiogenesis-related proteins, like vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR-2), in human breast cancer. We examined whether an association exists between expression of cyclin I, VEGFR-2, clinicopathologic parameters and survival of patients with epithelial ovarian cancer (EOC). Methods: Cyclin I and VEGFR-2 expressions were analyzed by immunohistochemistry in 55 human primary EOC tissue specimens. Results: Cyclin I immunoreactivity was significantly correlated with VEGFR-2 (R = 0.4587, P = 0.0004), and immunolabeling of cyclin I and VEGFR-2 significantly correlated with cancer cells' proliferative activity evaluated using cyclin A labeling index as a marker (R = 0.3107, P = 0.0209 and R = 0.4183, P = 0.0015, respectively). VEGFR-2 immunostaining was significantly higher in advanced, poorly differentiated, and suboptimally resected EOCs compared to their counterparts (P < 0.05). Finally, higher VEGFR-2 expression was significantly associated with shorter disease-free survival (P = 0.0437). Conclusions: Our results indicate that elevated expression of cyclin I and VEGFR-2 is likely to provide a proliferative advantage to the EOC cells, and that cyclin I may be linked with angiogenesis in EOC. Higher expression of VEGFR-2 is associated with more advanced disease. Further investigation of cyclin I in ovarian cancer is needed to evaluate if cyclin I may become a novel target for an anticancer therapy. © 2012 Elsevier Inc. Source

Discover hidden collaborations